Clinical Trials Browser

Prostatic Neoplasms × tazemetostat × Clear all

NCT07407283 2026-02-12

A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer

Phase 1/2 Not yet recruiting

Prostatic Neoplasms

NCT04846478 2025-04-17

Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC

Phase 1 Active not recruiting

Prostatic Neoplasms

NCT05567679 2023-09-22

A Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate Cancer

Phase EARLY_PHASE1 Withdrawn

Prostatic Neoplasms